Abstract
Despite being challenged more than a decade ago, fine-needle aspiration biopsy continues to have a valuable role in diagnosing lymphomas. An updated lymphoma classification and several advances in technologies have aided in its increased acceptance and use; however, now is the time to integrate fine-needle aspiration biopsy with ancillary studies and obtain material for potential molecular testing in the routine workup of lymphomas to ensure its continued use in the future.
Original language | English (US) |
---|---|
Pages (from-to) | 389-393 |
Number of pages | 5 |
Journal | Cancer Cytopathology |
Volume | 123 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2015 |
ASJC Scopus subject areas
- Oncology
- Cancer Research